Paws & Tails™
Product details
Corise Vetdox AQ 250mg Atovaquone Tablets for Dogs and Cats are a veterinary-prescribed antiprotozoal medication formulated to support the treatment of serious tick-borne and protozoal infections in companion animals. Containing Atovaquone 250mg, these tablets are commonly used as part of combination therapy protocols for managing conditions such as Babesiosis and Cytauxzoonosis in dogs and cats.
Effective antiprotozoal support for Babesia spp. and Cytauxzoon felis infections
Helps reduce parasitic load in red blood cells
Often used in combination with other prescribed medications for enhanced treatment outcomes
Suitable for both dogs and cats under veterinary supervision
Convenient tablet form for accurate dosing
Atovaquone works by inhibiting mitochondrial electron transport in protozoal organisms, disrupting their energy production and preventing further replication. This targeted mechanism helps control infection and supports your pet’s recovery when administered as directed by a veterinarian.
Corise Vetdox AQ 250mg Tablets are commonly prescribed for:
Canine Babesiosis
Feline Cytauxzoonosis
Certain other protozoal and tick-borne infections as diagnosed by a veterinarian
Use strictly under veterinary guidance.
Dosage is determined based on your pet’s weight, medical condition, and treatment protocol.
Tablets may be administered with food to improve absorption, unless otherwise directed by your veterinarian.
For veterinary use only.
Not recommended for use without confirmed diagnosis.
Inform your veterinarian of any existing medical conditions or concurrent medications.
Keep out of reach of children and other animals.
Corise Vetdox AQ 250mg Atovaquone Tablets provide reliable, veterinarian-recommended support in managing complex protozoal infections, helping restore your pet’s health and well-being with an effective, targeted treatment approach.
Similar products